Reference
- Sammaritano LR, Gharavi AE, Lockshin MD. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum 1990; 20(2): 81–96
- Lockshin MD. Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994; 20(l): 45–59
- Oeffinger KC, Roaten SP Jr. Antiphospholipid syndrome. J Fam Pract 1994; 38(6): 611–9
- Harris EN. Diagnosis and management of antiphospholipid syndrome. Hosp Pract 1994; 29(4): 65–76
- Vila P, Hernandez MC, Lopez-Fernandez MF, et al. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994; 72(2): 209–13
- Triplett DA. Antiphospholipid antibodies and thrombosis: a consequence, coincidence, or cause? Arch Pathol Lab Med 1993; 117(l): 78–88
- Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Ann Intern Med 1990; 112(9): 682–98
- Lynch A, Marlar R, Murphy J, et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome: a prospective study. Ann Intern Med 1994; 120(6): 470–510.
- Fields RA, Toubbeh H, Searles RP, et al. The prevalence of anti-cardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989; 16(5): 623–5
- Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117(12): 997–1002
- Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117(4): 303–8
- Brey RL, Hart RG, Sherman DG, et al. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40(8): 1190–6
- Muir KW, Squire IB, Alwan W, et al. Anticardiolipin antibodies in an unselected stroke population. Lancet 1994; 344(8920): 452–6
- Brey RL. Antiphospholipid antibodies and ischemic stroke. Heart Dis Stroke 1992; l(6): 379–82
- Kaplan SD, Chartash EK, Pizzarelio RA, et al. Cardiac manifestations of the antiphospholipid syndrome. Am Heart J 1992; 124(5): 1331–8
- Infante-Rivard C, David M, Gauthier R, et al. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss: a case-control study. N Engl J Med 1991; 325(15): 1063–6
- Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74(4): 1185–90
- Adcock DM, Marlar RA. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant. Arch Pathol Lab Med 1992; 116(8): 837–40
- Brigden ML, Ferguson DJ. Clinically appropriate investigations in cases of suspected lupus anticoagulant. (Letter) Am J Clin Pathol 1995; 103(3): 376
- Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other “antiphospholipid” autoantibodies. Blood 1994; 84(9): 2854–67
- Lockshin MD. Answers to the antiphospholipid-antibody syndrome? (Editorial) N EnglJ Med 1995; 332(15): 1025–7
- Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995: 332(15): 993–7
- Silver RK, MacGregor SN, Sholl JS, et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993 Dec; 169(6): 1411–7
- Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166(5): 1318–23
- Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79(1): 1–17